SUNNYVALE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. ("Silk Road") (NASDAQ:SILK), a leading minimally invasive medical device company focused on reducing the risk and impact of ...
Silk Road Medical's Study Designed to Validate Novel, Less Invasive Approach to Preventing Strokes During Repair of Carotid Artery Disease SUNNYVALE, Calif., Silk Road Medical, Inc., a company ...
Transcarotid artery revascularization (TCAR), which pulls in both surgical and endovascular techniques, is being rapidly adopted in the United States for the treatment of high-risk patients with ...
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has ...
Rosemont, Ill., Dec. 27, 2021 (GLOBE NEWSWIRE) -- A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were ...
Rosemont, Ill., Dec. 27, 2021 (GLOBE NEWSWIRE) -- A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were ...
Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques SUNNYVALE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results